Sangamo Files for CT Order 12/8/16

SECURITIES AND EXCHANGE COMMISSION
8 December 2016
ORDER GRANTING CONFIDENTIAL TREATMENT
UNDER THE SECURITIES EXCHANGE ACT OF 1934
Sangamo BioSciences, Inc.
File No. 0-30171 -- CF# 34340
_____________________
Sangamo BioSciences, Inc. submitted an application under Rule 24b-2 requesting
confidential treatment for information it excluded from the Exhibits to a Form 10-Q filed
on October 27, 2016.
Based on representations by Sangamo BioSciences, Inc. that this information
qualifies as confidential commercial or financial information under the Freedom of
Information Act, 5 U.S.C. 552(b)(4), the Division of Corporation Finance has determined
not to publicly disclose it. Accordingly, excluded information from the following
exhibit(s) will not be released to the public for the time period(s) specified:
Exhibit 10.1 through January 8, 2019
Exhibit 10.2 through July 10, 2022
Exhibit 10.3 through September 20, 2026
For the Commission, by the Division of Corporation Finance, pursuant to
delegated authority:
Brent J. Fields
Secretary